K2 HealthVentures — 2022 Investments

2 investments dated 2022 · listed companies and verified rows first · show all

EVERGREENevergreennephrology.cominMay 2022

HealthtechNashville, US

Matt Kim(Director)Adam Boehler(Director)Arjun Aggarwal(Director)Scott Lloyd(Executive Officer)Abe Sutton(Director)Eric Jenkins(Executive Officer)

OncXerna Therapeuticsoncxerna.comFeb 2022

BiotechWaltham, US

Chrystiyna Bedrij(Director)Peter Bisgaard(Director)Vincent Cheung(Director)Laura Benjamin(Director)Benjamin Chen(Director)

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.